Nxera Pharma Co., Ltd. (TYO:4565)
1,684.00
-61.00 (-3.50%)
Nov 18, 2026, 10:34 AM JST
Nxera Pharma Market Cap
Nxera Pharma has a market cap or net worth of 153.9 billion as of November 17, 2026. It is the 9,746th most valuable company in the world and the 730th biggest in Japan. Its market cap has increased by 97.98% in one year.
Market Cap
153.90B
Enterprise Value
189.25B
Revenue
35.51B
Global Rank
Country Rank
#730 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since July 29, 2004, Nxera Pharma's market cap has increased from 38.40B to 153.90B, an increase of 300.83%. That is a compound annual growth rate of 6.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 153.90B | 105.64% |
| Dec 30, 2025 | 74.84B | -20.57% |
| Dec 30, 2024 | 94.22B | -25.87% |
| Dec 29, 2023 | 127.10B | -27.43% |
| Dec 30, 2022 | 175.15B | 12.85% |
| Dec 30, 2021 | 155.21B | 7.00% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oncolys BioPharma | 238.75B |
| GNI Group | 149.19B |
| PeptiDream | 140.01B |
| Heartseed | 67.58B |
| SanBio Company | 65.10B |
| Cuorips | 53.82B |
| 3-D Matrix | 39.42B |
| Healios K.K. | 29.55B |